NASDAQ · STSSW
Financial Services · Financial - Capital Markets
$0.03
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 7:38 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
STSSW does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning STSSW.
STSSW research
Company profile and research snapshot.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Jun 11, 2025
Sharps Technology, an innovative medical device and pharmaceutical packaging company, announced that its CEO, Robert Hayes, will present at the Life Sciences Virtual Investor Forum on June 12th. The company recently commenced shipments under three customer orders, marking its transition to revenue-generating operations.
GlobeNewswire Inc. · May 22, 2025
Sharps Technology, a medical device and pharmaceutical packaging company, has received its first purchase orders for its SecureGard and SoloGard products, marking its transition from the pre-revenue qualification phase to revenue-generating commercial operations.
GlobeNewswire Inc. · Apr 24, 2025
Sharps Technology, Inc. announced a 1-for-300 reverse stock split to bring the company into compliance with Nasdaq's minimum bid price requirement. The reverse split will reduce the authorized common shares from 500,000,000 to 1,666,667.
GlobeNewswire Inc. · Mar 6, 2025
Sharps Technology secures $20 million in financing, advancing manufacturing capabilities in Hungary to accelerate shipments under existing agreements for SecureGard and SoloGard products. The company is well-positioned to capitalize on growing demand for innovative injection solutions.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning STSSW.
No results
No recent SID articles mention STSSW.
